|
ZNF41 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.31590360409018E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.30446822419617E-14 |
| Normal-vs-Stage2 |
6.84289999997034E-07 |
| Normal-vs-Stage3 |
9.62563362350011E-14 |
| Normal-vs-Stage4 |
2.20009566120893E-11 |
| Stage1-vs-Stage2 |
5.782400E-01 |
| Stage1-vs-Stage3 |
7.442300E-02 |
| Stage1-vs-Stage4 |
5.032100E-02 |
| Stage2-vs-Stage3 |
8.407800E-02 |
| Stage2-vs-Stage4 |
6.066000E-02 |
| Stage3-vs-Stage4 |
7.789600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33066907387547E-16 |
| Normal-vs-AfricanAmerican |
4.73010000001661E-06 |
| Normal-vs-Asian |
9.06420000168495E-08 |
| Caucasian-vs-AfricanAmerican |
8.206000E-01 |
| Caucasian-vs-Asian |
5.602200E-01 |
| AfricanAmerican-vs-Asian |
8.489200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.57649490420908E-11 |
| Normal-vs-Female |
1.62569957495862E-12 |
| Male-vs-Female |
4.256800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.40683078706661E-12 |
| Normal-vs-Age(41-60Yrs) |
2.94209101525666E-14 |
| Normal-vs-Age(61-80Yrs) |
1.74059988644615E-10 |
| Normal-vs-Age(81-100Yrs) |
3.019000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.750000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.321000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.017600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.835400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.986400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.583600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.061560E-01 |
| Classical-VS-Follicular |
7.785000E-01 |
| Classical-VS-Other |
2.404800E-01 |
| Classical-VS-Normal |
2.38190001056182E-09 |
| Tall-VS-Follicular |
1.971840E-01 |
| Tall-VS-Other |
6.863600E-01 |
| Tall-VS-Normal |
4.94740026724116E-10 |
| Follicular-VS-Other |
3.080600E-01 |
| Follicular-VS-Normal |
7.94449950269893E-10 |
| Other-VS-Normal |
6.235600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.08419956240868E-13 |
| Normal-vs-N1 |
2.49450460287903E-11 |
| N0-vs-N1 |
1.266570E-01 |
|
|
